1301 - 1350 of 8571 Results
Title
Year
-
OPENTitle: The End Is the Beginning: Parkinson’s Disease in the Light of Brain ImagingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00330Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2017.00330/pdfCitation Count: 34
- Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation2016RESTRICTEDTitle: Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulationJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 2Start Page: 274End Page: 277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26882Citation Count: 29
-
OPENTitle: Machine learning nominates the inositol pathway and novel genes in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 3Start Page: 887End Page: 899Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad345Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad345/51927901/awad345.pdfCitation Count: 18
- Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approach2022OPENTitle: Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approachJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1006567Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1006567/pdfCitation Count: 10
- Genetic Investigation of Consanguineous Pakistani Families Segregating Rare Spinocerebellar Disorders2023OPENTitle: Genetic Investigation of Consanguineous Pakistani Families Segregating Rare Spinocerebellar DisordersJournal Name: GenesPublisher: MDPI AGVol: 14Issue #: 7Start Page: 1404End Page: 1404Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/genes14071404Best OA location URL: https://www.mdpi.com/2073-4425/14/7/1404/pdf?version=1688622677Citation Count: 8
- Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain2023OPENTitle: Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brainJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00579-wBest OA location URL: https://www.nature.com/articles/s41531-023-00579-w.pdfCitation Count: 7
- Perspective: Evolution of Control Variables and Policies for Closed-Loop Deep Brain Stimulation for Parkinson’s Disease Using Bidirectional Deep-Brain-Computer Interfaces2020OPENTitle: Perspective: Evolution of Control Variables and Policies for Closed-Loop Deep Brain Stimulation for Parkinson’s Disease Using Bidirectional Deep-Brain-Computer InterfacesJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.00353Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.00353/pdfCitation Count: 31
- α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology2016OPENTitle: α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathologyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0532-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0532-8Citation Count: 33
-
RESTRICTEDTitle: Divalent metal ions control activity and inhibition of protein kinasesJournal Name: MetallomicsPublisher: Oxford University Press (OUP)Vol: 9Issue #: 11Start Page: 1576End Page: 1584Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c7mt00204aCitation Count: 52
- Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone2025OPENTitle: Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazoneJournal Name: PLOS OnePublisher: Public Library of Science (PLoS)Vol: 20Issue #: 5Start Page: e0309489End Page: e0309489Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0309489Best OA location URL: https://doi.org/10.1371/journal.pone.0309489Citation Count: 0
-
OPENTitle: miR-34a as hub of T cell regulation networksJournal Name: Journal for ImmunoTherapy of CancerPublisher: BMJVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40425-019-0670-5Best OA location URL: https://jitc.bmj.com/content/jitc/7/1/187.full.pdfCitation Count: 46
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5797696Citation Count: 58
-
OPENTitle: Deep Brain Stimulation associated gliosis: A post-mortem studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 54Issue #:Start Page: 51End Page: 55Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.009Best OA location URL: https://doi.org/10.1016/j.parkreldis.2018.04.009Citation Count: 29
- LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons2021OPENTitle: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neuronsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 1020End Page: 1048Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2021.1967615Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1967615?needAccess=trueCitation Count: 41
- Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein2020OPENTitle: Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synucleinJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aba1193Best OA location URL: https://advances.sciencemag.org/content/advances/6/18/eaba1193.full.pdfCitation Count: 58
- Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology2015OPENTitle: Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathologyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 131Issue #: 3Start Page: 393End Page: 409Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-015-1526-9Citation Count: 145
- Incorporating spatial constraint in co-activation pattern analysis to explore the dynamics of resting-state networks: An application to Parkinson's disease2018OPENTitle: Incorporating spatial constraint in co-activation pattern analysis to explore the dynamics of resting-state networks: An application to Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 172Issue #:Start Page: 64End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.01.019Citation Count: 35
- Longitudinal tracking of neuronal mitochondria delineates PINK1/Parkin-dependent mechanisms of mitochondrial recycling and degradation2021OPENTitle: Longitudinal tracking of neuronal mitochondria delineates PINK1/Parkin-dependent mechanisms of mitochondrial recycling and degradationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 32Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abf6580Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.abf6580Citation Count: 28
- Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 42018OPENTitle: Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4Journal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1337-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1337-8Citation Count: 42
- Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling2017OPENTitle: Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signalingJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0153-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0153-4Citation Count: 51
-
OPENTitle: Estimation of genetic risk function with covariates in the presence of missing genotypesJournal Name: Statistics in MedicinePublisher: WileyVol: 36Issue #: 22Start Page: 3533End Page: 3546Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/sim.7376Best OA location URL: https://arxiv.org/pdf/1705.09591Citation Count: 4
- Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis2021OPENTitle: Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease PsychosisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.633645Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.633645/pdfCitation Count: 7
-
OPENTitle: Neural heterogeneity controls computations in spiking neural networksJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1073/pnas.2311885121Best OA location URL: https://pnas.org/doi/pdf/10.1073/pnas.2311885121Citation Count: 30
-
RESTRICTEDTitle: Cognitive dysfunction in Tunisian LRRK2 associated Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 3Start Page: 243End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.10.009Citation Count: 46
- An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson's disease2024OPENTitle: An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 125Issue #:Start Page: 107019End Page: 107019Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107019Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107019Citation Count: 2
- Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard2019RESTRICTEDTitle: Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide StandardJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 6Start Page: 2422End Page: 2432Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00920Citation Count: 15
-
OPENTitle: Importance of low diagnostic Accuracy for early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1551End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27485Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6544441Citation Count: 109
- Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease2023OPENTitle: Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 17Start Page: 13435End Page: 13435Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241713435Best OA location URL: https://www.mdpi.com/1422-0067/24/17/13435/pdf?version=1693464631Citation Count: 4
-
OPENTitle: Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 5Start Page: 893End Page: 906Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25897Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25897Citation Count: 82
- DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.2017RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20
-
RESTRICTEDTitle: Transdermal Nicotine Treatment and Progression of Early Parkinson’s DiseaseJournal Name: NEJM EvidencePublisher: Massachusetts Medical SocietyVol: 2Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1056/evidoa2200311Citation Count: 16
- Modeling and optimizing deep brain stimulation to enhance gait in Parkinson’s disease: personalized treatment with neurophysiological insights2025OPENTitle: Modeling and optimizing deep brain stimulation to enhance gait in Parkinson’s disease: personalized treatment with neurophysiological insightsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00990-5Best OA location URL: https://www.nature.com/articles/s41531-025-00990-5.pdfCitation Count: 0
- Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein2020OPENTitle: Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00380-wBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00380-wCitation Count: 13
-
OPENTitle: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 3Start Page: 1218End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294Best OA location URL: https://doi.org/10.7270/q280562cCitation Count: 23
-
OPENTitle: Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell FunctionJournal Name: Molecular Therapy Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2020.05.009Best OA location URL: http://www.cell.com/article/S2162253120301359/pdfCitation Count: 11
- Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's Disease2023OPENTitle: Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 9Start Page: 1655End Page: 1667Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29510Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29510Citation Count: 14
-
OPENTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participantsJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page: 7End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000680Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7057071Citation Count: 23
- Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity2016OPENTitle: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease SeverityJournal Name: Oxidative Medicine and Cellular LongevityPublisher: WileyVol: 2016Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/9409363Best OA location URL: http://downloads.hindawi.com/journals/omcl/2016/9409363.pdfCitation Count: 78
-
OPENTitle: Genetic architecture of subcortical brain structures in 38,851 individualsJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 51Issue #: 11Start Page: 1624End Page: 1636Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-019-0511-yBest OA location URL: https://www.nature.com/articles/s41588-019-0511-y.pdfCitation Count: 253
- Oral Transport, Penetration, and Aspiration in PD: Insights from a RCT on STN + SNr Stimulation2024RESTRICTEDTitle: Oral Transport, Penetration, and Aspiration in PD: Insights from a RCT on STN + SNr StimulationJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 40Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00455-024-10779-yCitation Count: 0
- Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder2025OPENTitle: Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior DisorderJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.27263Citation Count: 0
- Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 Delivery2023OPENTitle: Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 DeliveryJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 9Start Page: 1728End Page: 1736Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29518Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29518Citation Count: 13
- A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells2023OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202309306Citation Count: 0
- Unique nigral and cortical pathways implicated by epigenomic and transcriptional analyses in rotenone Parkinson’s model2025OPENTitle: Unique nigral and cortical pathways implicated by epigenomic and transcriptional analyses in rotenone Parkinson’s modelJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01049-1Best OA location URL: https://www.nature.com/articles/s41531-025-01049-1.pdfCitation Count: 0
- Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins2021OPENTitle: Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteinsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2005894118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7958464Citation Count: 81
- Cognitive phenotypes in parkinson's disease differ in terms of brain‐network organization and connectivity2016OPENTitle: Cognitive phenotypes in parkinson's disease differ in terms of brain‐network organization and connectivityJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 3Start Page: 1604End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23474Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/5ec5c003-ce6c-4e99-b9c0-122da15fd2b1Citation Count: 88
-
OPENTitle: Tau protein aggregation is associated with cellular senescence in the brainJournal Name: Aging CellPublisher: WileyVol: 17Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.12840Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.12840Citation Count: 489
- Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment2023OPENTitle: Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairmentJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1069411Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1069411/pdfCitation Count: 42
-
OPENTitle: Autophagic stress activates distinct compensatory secretory pathways in neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 122Issue #: 28Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2421886122Best OA location URL: https://www.pnas.org/doi/pdf/10.1073/pnas.2421886122Citation Count: 1
-
OPENTitle: Toward the quantification of α-synuclein aggregates with digital seed amplification assaysJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2312031121Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10801878Citation Count: 14